• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination

13 de February de 2013
J Exp Med. 2013 Mar 11;210(3):563-79. doi: 10.1084/jem.20120662.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-02-13 11:00:002013-02-13 11:00:00Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination

ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor

8 de January de 2013
Int J Cancer. 2013 Jul;133(1):235-46. doi: 10.1002/ijc.28009.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-01-08 11:00:002013-01-08 11:00:00ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor

Anti-angiogenesis and metastasis: a tumour and stromal cell alliance

4 de December de 2012
J Intern Med. 2013 Feb;273(2):128-37. doi: 10.1111/joim.12018.ABSTRACTTumour…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2012-12-04 11:00:002012-12-04 11:00:00Anti-angiogenesis and metastasis: a tumour and stromal cell alliance

Progeny of Lgr5-expressing hair follicle stem cell contributes to papillomavirus-induced tumor development in epidermis

5 de September de 2012
Oncogene. 2013 Aug 8;32(32):3732-43. doi: 10.1038/onc.2012.375.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2012-09-05 10:00:002012-09-05 10:00:00Progeny of Lgr5-expressing hair follicle stem cell contributes to papillomavirus-induced tumor development in epidermis

Relevance of angiogenesis in neuroendocrine tumors

18 de May de 2012
Target Oncol. 2012 Jun;7(2):93-8. doi: 10.1007/s11523-012-0217-x.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2012-05-18 10:00:002012-05-18 10:00:00Relevance of angiogenesis in neuroendocrine tumors

Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice

10 de April de 2012
J Clin Invest. 2012 May;122(5):1832-48. doi: 10.1172/JCI58976.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2012-04-10 10:00:002012-04-10 10:00:00Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice

Cancer: Limitations of therapies exposed

7 de April de 2012
Nature. 2012 Apr 4;484(7392):44-6. doi: 10.1038/484044a.NO ABSTRACTPMID:22481354…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2012-04-07 10:00:002012-04-07 10:00:00Cancer: Limitations of therapies exposed

Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling

20 de March de 2012
Nature. 2012 Mar 18;484(7392):110-4. doi: 10.1038/nature10908.ABSTRACTDeveloping…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2012-03-20 10:00:002012-03-20 10:00:00Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling

Exploiting pleiotropic activities of semaphorins as multi-target therapies for cancer

11 de February de 2012
EMBO Mol Med. 2012 Mar;4(3):168-70. doi: 10.1002/emmm.201200206.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2012-02-11 11:00:002012-02-11 11:00:00Exploiting pleiotropic activities of semaphorins as multi-target therapies for cancer

Use of a mouse model of pancreatic neuroendocrine tumors to find pericyte biomarkers of resistance to anti-angiogenic therapy

1 de October de 2011
Horm Metab Res. 2011 Nov;43(12):884-9. doi: 10.1055/s-0031-1284381.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2011-10-01 10:00:002011-10-01 10:00:00Use of a mouse model of pancreatic neuroendocrine tumors to find pericyte biomarkers of resistance to anti-angiogenic therapy

Non-invasive monitoring of hypoxia-inducible factor activation by optical imaging during antiangiogenic treatment in a xenograft model of ovarian carcinoma

14 de June de 2011
Int J Oncol. 2011 Sep;39(3):543-52. doi: 10.3892/ijo.2011.1074.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2011-06-14 10:00:002011-06-14 10:00:00Non-invasive monitoring of hypoxia-inducible factor activation by optical imaging during antiangiogenic treatment in a xenograft model of ovarian carcinoma

Glycolytic phenotype and AMP kinase modify the pathologic response of tumor xenografts to VEGF neutralization

7 de May de 2011
Cancer Res. 2011 Jun 15;71(12):4214-25. doi: 10.1158/0008-5472.CAN-11-0242.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2011-05-07 10:00:002011-05-07 10:00:00Glycolytic phenotype and AMP kinase modify the pathologic response of tumor xenografts to VEGF neutralization
Page 5 of 7«‹34567›»

Filter by categories

  • Alemany’s & Piulats’s lab (131)
  • Antolin's lab (36)
  • Aytes's Lab (24)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sureda's & Farre's Lab (259)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}